(Bloomberg) -- Reckitt Benckiser Plc is ramping up manufacturing in the US and China to bolster its supply chain and potentially lessen its exposure to fresh trade wars. The maker of Strepsils ...

Reckitt Benckiser shares fell after a U.S. judge ordered a retrial of an infant-formula lawsuit that had found in the consumer-goods company's favor. In afternoon trading Friday, London-listed ...

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over allegations their premature infant formula can cause a serious gut condition.

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in ...